{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T13:38:02Z","timestamp":1777729082995,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002770","name":"Cabinet Office Government of Japan","doi-asserted-by":"publisher","award":["JPCAFSC20232301"],"award-info":[{"award-number":["JPCAFSC20232301"]}],"id":[{"id":"10.13039\/501100002770","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.dmpk.2025.101505","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T06:47:57Z","timestamp":1761288477000},"page":"101505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Cytochrome P450 inhibition correlates with hepatotoxicity of pesticides: Analysis using repeated-dose toxicity data in rats"],"prefix":"10.1016","volume":"66","author":[{"given":"Minami","family":"Shibata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8697-7733","authenticated-orcid":false,"given":"Akira","family":"Ooka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Shizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2027-2017","authenticated-orcid":false,"given":"Kouichi","family":"Yoshinari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.dmpk.2025.101505_bib1","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL clinical practice guidelines: drug-induced liver injury","volume":"70","year":"2019","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.dmpk.2025.101505_bib2","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/hep.23937","article-title":"Acute Liver Failure Study G. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study","volume":"52","author":"Reuben","year":"2010","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.dmpk.2025.101505_bib3","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrd4309","article-title":"Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework","volume":"13","author":"Cook","year":"2014","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"10.1016\/j.dmpk.2025.101505_bib4","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/clpt.2011.63","article-title":"Drug safety sciences and the bottleneck in drug development","volume":"89","author":"Watkins","year":"2011","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.dmpk.2025.101505_bib5","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nrd2423","article-title":"Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges","volume":"6","author":"Wilke","year":"2007","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"10.1016\/j.dmpk.2025.101505_bib6","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1080\/10937404.2023.2261848","article-title":"Drug induced liver injury - a 2023 update","volume":"26","author":"Allison","year":"2023","journal-title":"J Toxicol Environ Health B Crit Rev"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101505_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00018-023-05061-7","article-title":"Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction","volume":"81","author":"LeFort","year":"2024","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101505_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10030390","article-title":"Oxidative stress in drug-induced liver injury (DILI): from mechanisms to biomarkers for use in clinical practice","volume":"10","author":"Villanueva-Paz","year":"2021","journal-title":"Antioxidants"},{"issue":"9","key":"10.1016\/j.dmpk.2025.101505_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094557","article-title":"Immune-Mediated drug-induced liver injury: immunogenetics and experimental models","volume":"22","author":"Gerussi","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.dmpk.2025.101505_bib10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrd792","article-title":"Cytochrome P450 enzymes in the generation of commercial products","volume":"1","author":"Guengerich","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.dmpk.2025.101505_bib11","series-title":"Cytochrome P450: structure, mechanism, and biochemistry","first-page":"523","article-title":"Human cytochrome P450 enzymes","author":"Guengerich","year":"2015"},{"issue":"9","key":"10.1016\/j.dmpk.2025.101505_bib12","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2174\/138920021131400114","article-title":"Mechanism-based inhibition of CYP450: an indicator of drug-induced hepatotoxicity","volume":"14","author":"Feng","year":"2013","journal-title":"Curr Drug Metabol"},{"issue":"4","key":"10.1016\/j.dmpk.2025.101505_bib13","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1248\/yakushi.14-00249-2","article-title":"[Establishment of animal models of drug-induced liver injury and analysis of possible mechanisms]","volume":"135","author":"Oda","year":"2015","journal-title":"Yakugaku Zasshi"},{"issue":"4","key":"10.1016\/j.dmpk.2025.101505_bib14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2131\/jts.46.167","article-title":"Association of CYP1A1 and CYP1B1 inhibition in in vitro assays with drug-induced liver injury","volume":"46","author":"Shimizu","year":"2021","journal-title":"J Toxicol Sci"},{"issue":"9","key":"10.1016\/j.dmpk.2025.101505_bib15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2131\/jts.47.359","article-title":"Involvement of the CYP1A1 inhibition-mediated activation of aryl hydrocarbon receptor in drug-induced hepatotoxicity","volume":"47","author":"Yoda","year":"2022","journal-title":"J Toxicol Sci"},{"key":"10.1016\/j.dmpk.2025.101505_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2025.115566","article-title":"Utility of in vitro assay data in read-across prediction of nongenotoxic carcinogenicity of pesticides for cytotoxicity-related rat tumors","volume":"202","author":"Mizuno","year":"2025","journal-title":"Food Chem Toxicol"},{"issue":"5","key":"10.1016\/j.dmpk.2025.101505_bib17","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1248\/yakushi.16-00259","article-title":"[Construction of the Database of Rat Repeated-dose Toxicity Tests of Pesticides for the Toxicological Characterization of Hepatocyte Hypertrophy]","volume":"137","author":"Masuda","year":"2017","journal-title":"Yakugaku Zasshi"},{"issue":"11","key":"10.1016\/j.dmpk.2025.101505_bib18","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1021\/acs.chemrestox.4c00168","article-title":"Machine learning-based in Silico prediction of the inhibitory activity of chemical substances against rat and human cytochrome P450s","volume":"37","author":"Ambe","year":"2024","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.dmpk.2025.101505_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2019.114854","article-title":"Application of cytochrome P450 reactivity on the characterization of chemical compounds and its association with repeated-dose toxicity","volume":"388","author":"Watanabe","year":"2020","journal-title":"Toxicol Appl Pharmacol"},{"issue":"7","key":"10.1016\/j.dmpk.2025.101505_bib20","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/00498254.2024.2312505","article-title":"Utility of human cytochrome P450 inhibition data in the assessment of drug-induced liver injury","volume":"54","author":"Kaito","year":"2024","journal-title":"Xenobiotica"},{"issue":"9","key":"10.1016\/j.dmpk.2025.101505_bib21","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1124\/dmd.114.057836","article-title":"Characterization of arachidonic acid metabolism by rat cytochrome P450 enzymes: the involvement of CYP1As","volume":"42","author":"El-Sherbeni","year":"2014","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101505_bib22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.yexcr.2019.04.029","article-title":"Epoxyeicosatrienoic intervention improves NAFLD in leptin receptor deficient mice by an increase in PGC1alpha-HO-1-PGC1alpha-mitochondrial signaling","volume":"380","author":"Raffaele","year":"2019","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.dmpk.2025.101505_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1874073100701010001","article-title":"Novel role of soluble epoxide hydrolase in regulating cholesterol in Mammalian cells","volume":"1","author":"Enayetallah","year":"2007","journal-title":"Open Drug Metabol J"},{"key":"10.1016\/j.dmpk.2025.101505_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2025.106075","article-title":"Association between drug-induced heart failure and CYP1A1, CYP1B1, and CYP3A4 inhibition: Utility of cytochrome P450 inhibition assay for evaluating cardiotoxicity of drug candidates","volume":"107","author":"Kaito","year":"2025","journal-title":"Toxicol In Vitro"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436725004550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436725004550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T15:12:20Z","timestamp":1774624340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436725004550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":24,"alternative-id":["S1347436725004550"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2025.101505","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytochrome P450 inhibition correlates with hepatotoxicity of pesticides: Analysis using repeated-dose toxicity data in rats","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2025.101505","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101505"}}